Validation of performance of the gen-probe human immunodeficiency virus type 1 viral load assay with genital swabs and breast milk samples.
about
Low serum albumin and the acute phase response predict low serum selenium in HIV-1 infected women.Highly active antiretroviral therapy versus zidovudine/nevirapine effects on early breast milk HIV type-1 Rna: a phase II randomized clinical trialLongitudinal assessment of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon responses during the first year of life in HIV-1-infected infants.A prospective study of vaginal trichomoniasis and HIV-1 shedding in women on antiretroviral therapy.CCR5, RANTES and SDF-1 polymorphisms and mother-to-child HIV-1 transmission.Longitudinal analysis of human immunodeficiency virus type 1 RNA in breast milk and of its relationship to infant infection and maternal diseaseAntiretroviral adherence and development of drug resistance are the strongest predictors of genital HIV-1 shedding among women initiating treatmentReal-time PCR quantification of genital shedding of herpes simplex virus (HSV) and human immunodeficiency virus (HIV) in women coinfected with HSV and HIV.Genital ulceration does not increase HIV-1 shedding in cervical or vaginal secretions of women taking antiretroviral therapy.Correlates and outcomes of preterm birth, low birth weight, and small for gestational age in HIV-exposed uninfected infantsShort-term effect of zidovudine on plasma and genital human immunodeficiency virus type 1 and viral turnover in these compartments.Breast milk HIV-1 RNA levels and female sex are associated with HIV-1-specific CD8+ T-cell responses in HIV-1-exposed, uninfected infants in KenyaRisk factors for neonatal conjunctivitis in babies of HIV-1 infected mothers.Depot Medroxyprogesterone Acetate Use Is Associated With Elevated Innate Immune Effector Molecules in Cervicovaginal Secretions of HIV-1-Uninfected WomenValacyclovir suppressive therapy reduces plasma and breast milk HIV-1 RNA levels during pregnancy and postpartum: a randomized trial.C868T single nucleotide polymorphism and HIV type 1 disease progression among postpartum women in Kenya.Early response to highly active antiretroviral therapy in HIV-1-infected Kenyan children.Breast milk HIV-1 suppression and decreased transmission: a randomized trial comparing HIVNET 012 nevirapine versus short-course zidovudine.Breast milk alpha-defensins are associated with HIV type 1 RNA and CC chemokines in breast milk but not vertical HIV type 1 transmission.Subtype C Is associated with increased vaginal shedding of HIV-1.Antiretroviral treatment interruptions predict female genital shedding of genotypically resistant HIV-1 RNA.HIV-1-specific enzyme-linked immunosorbent spot assay responses in HIV-1-exposed uninfected partners in discordant relationships compared to those in low-risk controls.Genital Inflammation Predicts HIV-1 Shedding Independent of Plasma Viral Load and Systemic Inflammation.Genital Shedding of Resistant Human Immunodeficiency Virus-1 Among Women Diagnosed With Treatment Failure by Clinical and Immunologic MonitoringBreast milk cellular HIV-specific interferon γ responses are associated with protection from peripartum HIV transmission.Lower risk of resistance after short-course HAART compared with zidovudine/single-dose nevirapine used for prevention of HIV-1 mother-to-child transmissionHIV-1 persists in breast milk cells despite antiretroviral treatment to prevent mother-to-child transmission.Salivary human immunodeficiency virus (HIV)-1-specific immunoglobulin A in HIV-1-exposed infants in Kenya.Infants with late breast milk acquisition of HIV-1 generate interferon-gamma responses more rapidly than infants with early peripartum acquisition.Infant CD4 C868T polymorphism is associated with increased human immunodeficiency virus (HIV-1) acquisition
P2860
Q33244104-FF37ED71-E1FF-4C39-AB12-6A74C7492199Q33811136-19DF8AFD-9072-40D0-B338-36AC9BDE995CQ33843438-2E87857A-31FD-412F-BF88-F52A1C954092Q34065082-B28756C6-EEB7-47C5-B075-F8D1AA81CFB7Q34070784-B7CDAF7C-0C24-41D8-B283-E83686362FD5Q34179093-9ECBD0FA-65EF-46B1-B188-421DE9A20BD6Q34213285-A3DEAEFC-5DAF-456E-8057-404FF241FACEQ34430752-865E2931-E6DD-40D2-BFCB-ADE012CC507BQ34846749-E51A3261-F627-4C85-B4B9-2B7FEA66C624Q35084426-AB0B3026-697F-419B-A3F7-C45C9F6C9671Q35149835-ED7C1E9A-463F-4655-B20A-CAD68365A01BQ35463763-F06F2AB5-C3E3-46BA-B1A4-6FC6467D7918Q35570693-3E13D870-28EB-4B48-B58B-A34FB12D2550Q35582308-7656F69F-9058-4CEC-9F68-82FC485667E2Q35669036-DC4D890B-F90A-4476-A2C4-4C2F1EE0E083Q35979691-F70518F5-CE80-47DF-A09E-C2873C63A02DQ36048997-B28E7C5F-A507-4EBF-9780-6D80F825FC4EQ36052959-C89AD312-09AC-457E-9CCC-C986B601FB12Q36055623-A1E6E8D9-1709-4E17-95D6-4520B96DF365Q36069347-D751EFC8-9F15-4698-B7B4-4143F8ED1ED6Q36113560-D5A08602-BB5B-479D-B92B-7E5220DA928DQ36378669-E2BF37F8-A314-494F-ABC1-EE25D1A4B19FQ36389094-FFF90F89-42B2-4AA7-90B1-3D0DD1775B16Q36667251-0EABDCD3-0775-4855-9F34-32E6DF331812Q37032208-F71BB29B-643C-4357-ABCD-DA780F38B982Q37396569-51FDCD30-B2E9-4EBF-BB79-A8E8C900E8F0Q37396586-C79AADBC-0D27-4553-A0B8-6F35F70AE409Q45394795-8A65C1F2-3D1D-46F7-B6DD-F2F0FC2EB3B7Q47812016-CCA5CFD8-0527-4E35-81F0-C24213AE9EB7Q56998154-70C0A778-BBE4-4537-8085-C791041709EA
P2860
Validation of performance of the gen-probe human immunodeficiency virus type 1 viral load assay with genital swabs and breast milk samples.
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Validation of performance of t ...... swabs and breast milk samples.
@ast
Validation of performance of t ...... swabs and breast milk samples.
@en
Validation of performance of t ...... swabs and breast milk samples.
@nl
type
label
Validation of performance of t ...... swabs and breast milk samples.
@ast
Validation of performance of t ...... swabs and breast milk samples.
@en
Validation of performance of t ...... swabs and breast milk samples.
@nl
prefLabel
Validation of performance of t ...... swabs and breast milk samples.
@ast
Validation of performance of t ...... swabs and breast milk samples.
@en
Validation of performance of t ...... swabs and breast milk samples.
@nl
P2093
P2860
P1476
Validation of performance of t ...... swabs and breast milk samples.
@en
P2093
Christine Rousseau
Dana DeVange Panteleeff
Joan K Kreiss
Sandra Emery
Sarah Benki
Sharon Bodrug
P2860
P304
P356
10.1128/JCM.40.11.3929-3937.2002
P407
P577
2002-11-01T00:00:00Z